Cargando…

Characteristics of humoral and cellular responses to coronavirus disease 2019 (COVID-19) inactivated vaccine in central China: A prospective, multicenter, longitudinal study

INTRODUCTION: In China, the long-term immunogenicity and adverse effects of inactivated vaccines produced by different or the same manufacturer remain unclear. Therefore, the objective of this study was to evaluate the cellular immune responses and neutralizing antibody kinetics of homologous and he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Youhua, Xu, Junhong, Ma, Bing, Chen, Guohua, Wang, Zhibin, Wang, Shanmei, Jing, Nan, Zhang, Jiangfeng, Wang, Baoya, Yan, Wenjuan, Zhang, Qi, Zhao, Qiongrui, Li, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020218/ https://www.ncbi.nlm.nih.gov/pubmed/36936962 http://dx.doi.org/10.3389/fimmu.2023.1107866

Ejemplares similares

Microbiological Analysis and Mortality Risk Factors in Patients with Polymicrobial Bloodstream Infections
por: Xu, Junhong, et al.
Publicado: (2023)

The first imported case of melioidosis in a patient in central China
por: Yuan, Youhua, et al.
Publicado: (2019)

Early predictors of severe COVID‐19 among hospitalized patients
por: Zhao, Qiongrui, et al.
Publicado: (2021)

Validation of a predictive model for coronary artery disease in patients with diabetes
por: Xu, Junhong, et al.
Publicado: (2023)

Evaluation of an optimized method to directly identify bacteria from positive blood cultures using MALDI‐TOF mass spectrometry
por: Yuan, Youhua, et al.
Publicado: (2019)

Prevalence and Genetic Diversity of Clostridium perfringens Isolates in Hospitalized Diarrheal Patients from Central China
por: Wang, Baoya, et al.
Publicado: (2021)

Evaluation of the Autof MS1000 mass spectrometer in the identification of clinical isolates
por: Ma, Qiong, et al.
Publicado: (2020)

Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for mcr-Positive and Negative Escherichia coli and Klebsiella pneumoniae in China
por: Zhang, Qi, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA Load Status and Antibody Distribution Among Patients and Asymptomatic Carriers in Central China
por: Yuan, Youhua, et al.
Publicado: (2021)

Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes
por: Yuan, Youhua, et al.
Publicado: (2020)

Non-tuberculous Mycobacterial Infection of the Musculoskeletal System Detected at Two Tertiary Medical Centres in Henan, China, 2016–2020
por: Ma, Qiong, et al.
Publicado: (2021)

Novel Inactivated Subtype B Avian Metapneumovirus Vaccine Induced Humoral and Cellular Immune Responses
por: Bao, Yuanling, et al.
Publicado: (2020)

The vaccinia‐based Sementis Copenhagen Vector coronavirus disease 2019 vaccine induces broad and durable cellular and humoral immune responses
por: Eldi, Preethi, et al.
Publicado: (2022)

Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice
por: Barroso, Shana P. C., et al.
Publicado: (2015)

Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight
por: Zhu, Qian, et al.
Publicado: (2022)

Immune response after vaccination using inactivated vaccine for coronavirus disease 2019
por: Sun, Ya, et al.
Publicado: (2023)

Systematic review of the effects of environmental factors on virus inactivation: implications for coronavirus disease 2019
por: Guo, L., et al.
Publicado: (2021)

Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab
por: Hall, Victoria G, et al.
Publicado: (2023)

An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV
por: Zhang, Haili, et al.
Publicado: (2022)

Cellular and Humoral Responses to Recombinant and Inactivated SARS-CoV-2 Vaccines in CKD Patients: An Observational Study
por: Zhang, Siliang, et al.
Publicado: (2023)

Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination
por: Yoshida, Makoto, et al.
Publicado: (2023)

Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy
por: Wang, Wen-Xin, et al.
Publicado: (2022)

Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus
por: Chang, Chi-Chieh, et al.
Publicado: (2023)

Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease
por: Nagant, Carole, et al.
Publicado: (2019)

Immuno-modulatory Effects of Inactivated Dietzia Maris on the Selected Aspects of Cellular and Humoral Immune Responses in Mice
por: Nofouzi, Katayoon, et al.
Publicado: (2023)

Balanced Cellular and Humoral Immune Responses Targeting Multiple Antigens in Adults Receiving a Quadrivalent Inactivated Influenza Vaccine
por: Yu, Esther Dawen, et al.
Publicado: (2021)

Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China
por: Guo, Jun, et al.
Publicado: (2023)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
por: Méndez, Constanza, et al.
Publicado: (2023)

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone
por: Cheng, Chongsheng, et al.
Publicado: (2022)

Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis
por: Atahan, Ersan, et al.
Publicado: (2023)

Radiation-Inactivated S. gallinarum Vaccine Provides a High Protective Immune Response by Activating Both Humoral and Cellular Immunity
por: Ji, Hyun Jung, et al.
Publicado: (2021)

Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant
por: Yang, Ning, et al.
Publicado: (2022)

Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting
por: Li, Ziwei, et al.
Publicado: (2021)

Coronavirus Disease 2019 and the Injured Patient: A Multicenter Review
por: Hakmi, Hazim, et al.
Publicado: (2022)

Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination
por: Liang, Boyun, et al.
Publicado: (2022)

Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine
por: Yang, Jinyoung, et al.
Publicado: (2023)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses
por: Bai, Bingke, et al.
Publicado: (2008)

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
por: Chen, Zhiwei, et al.
Publicado: (2022)

Inactivation of coronaviruses by heat
por: Kampf, G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jqb7c0mh5h0i1ubolh1l469s3f